<- Go Home
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Market Cap
$85.3K
Volume
112.4K
Cash and Equivalents
$4.1M
EBITDA
-$9.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$7.47
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.02
Price / Earnings
-0.01
Price / Tangible Book Value
0.02
Enterprise Value
-$3.6M
Enterprise Value / EBITDA
0.39
Operating Income
-$9.5M
Return on Equity
113.96%
Return on Assets
-61.57
Cash and Short Term Investments
$4.1M
Debt
$451.0K
Equity
$3.4M
Revenue
N/A
Unlevered FCF
-$5.4M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium